June 26, 2017 10:50 PM ET

Pharmaceuticals

Company Overview of DAN Immunotherapy Ltd.

Company Overview

DAN Immunotherapy, Ltd. develops therapeutic cancer vaccines. It operates in the immunotherapy pharmaceutical market section. The company uses bioinformatics-designed multiepitope polypeptide technology, suited for the vaccination of cancer patients. DAN Immunotherapy was founded in 2004 and is based in Kiryat Shmona, Israel.

Southern Industrial Zone

Kiryat Shmona,  11013

Israel

Founded in 2004

Phone:

972 4 681 8808

Fax:

972 4 681 8806

Key Executives for DAN Immunotherapy Ltd.

Chief Executive Officer
Founder and Chief Scientific Officer
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
Abital Pharma Pipelines Ltd. Middle East/Africa
Active PX Ltd. Middle East/Africa
Advanced Inhalation Technology Ltd. Middle East/Africa
AIT Therapeutics, Inc. Middle East/Africa
Angio B Ltd. Middle East/Africa

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact DAN Immunotherapy Ltd., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.